Literature DB >> 8405444

Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload.

R Yorikane1, S Sakai, T Miyauchi, T Sakurai, Y Sugishita, K Goto.   

Abstract

Endothelin-1 (ET-1) has been demonstrated to induce hypertrophy in cultured cardiac myocytes. We investigated the production of ET-1 in the heart of aorta-banded rats in vivo. Seven days after the banding of the abdominal aorta, rats developed a significant left ventricular hypertrophy. The tissue content of mature ET-1 and the level of expression of prepro ET-1 mRNA were higher in the left ventricle of aorta-banded rats than in those of sham-operated rats. The expression of prepro ET-1 mRNA in the right ventricle was not different between the two groups. These findings indicate that the production of ET-1 increased in the hypertrophied left ventricle, thereby suggesting the possible involvement of endogenous ET-1 in the development of cardiac hypertrophy due to pressure overload.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405444     DOI: 10.1016/0014-5793(93)80476-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

Review 2.  Cardiac inositol 1,4,5-trisphosphate receptors.

Authors:  M Iveth Garcia; Darren Boehning
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-11-22       Impact factor: 4.739

3.  Time course studies on the functional evaluation of experimental chronic myocardial infarction in rats.

Authors:  Panchatcharam Manikandan; Miriyala Sumitra; Mohammed Nayeem; Bhakthavatsalam Murali Manohar; Beema Lokanadam; Subbiah Vairamuthu; Samu Subramaniam; Rengarajulu Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.

Authors:  Maria Valero-Munoz; Shanpeng Li; Richard M Wilson; Batbold Boldbaatar; Marc Iglarz; Flora Sam
Journal:  Circ Heart Fail       Date:  2016-11       Impact factor: 8.790

5.  Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension.

Authors:  M A Al-Omari; M Khaleghi; T H Mosley; N G Morgenthaler; J Struck; A Bergmann; I J Kullo
Journal:  J Hum Hypertens       Date:  2010-02-25       Impact factor: 3.012

6.  Functionally redundant control of cardiac hypertrophic signaling by inositol 1,4,5-trisphosphate receptors.

Authors:  M Iveth Garcia; Anja Karlstaedt; Jessica J Chen; Javier Amione-Guerra; Keith A Youker; Heinrich Taegtmeyer; Darren Boehning
Journal:  J Mol Cell Cardiol       Date:  2017-09-18       Impact factor: 5.000

Review 7.  Endothelin and heart failure.

Authors:  P Nambi; M Clozel; G Feuerstein
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

8.  Aldosterone modulates steroid receptor binding to the endothelin-1 gene (edn1).

Authors:  Lisa R Stow; Michelle L Gumz; I Jeanette Lynch; Megan M Greenlee; Alicia Rudin; Brian D Cain; Charles S Wingo
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

9.  Involvement of endothelin-1 in habitual exercise-induced increase in arterial compliance.

Authors:  S Maeda; J Sugawara; M Yoshizawa; T Otsuki; N Shimojo; S Jesmin; R Ajisaka; T Miyauchi; H Tanaka
Journal:  Acta Physiol (Oxf)       Date:  2008-10-04       Impact factor: 6.311

10.  Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.

Authors:  Se Min Ryu; Hark Jei Kim; Kyu Ran Cho; Won-Min Jo
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.